| Dr Michael Kenneth Mesisca, DO | |
|
400 N Pepper Ave, Colton, CA 92324-1801 | |
| (909) 580-6370 | |
| Not Available |
| Full Name | Dr Michael Kenneth Mesisca |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 400 N Pepper Ave, Colton, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831426840 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20A10981 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside University Health System-medical Center | Moreno valley, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
| County Of Riverside | 6507754488 | 97 |
News Archive
The Indian government plans to set up orphanages in each regional district for female infants in an effort to curb sex-selective abortions, Renuka Chowdhury, minister of women and child development, said, the PTI/Hindustan Times reports.
Aragon Pharmaceuticals today announced the dosing of the first patient in a Phase 1/2 clinical trial of the company's lead compound, ARN-509, in patients with castration-resistant prostate cancer (CRPC).
The study results revealed that patients with a history of heart disease who stopped taking a low-dose daily aspirin had a 60% increased risk of having a heart attack over the three-year follow-up, compared with patients who continued the daily aspirin, says study researcher Luis A. Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research (CEIFE) in Madrid. The study is published in the British Medical Journal.
The National Institutes of Health has awarded grants totaling $3 million for two nanoparticle research projects in which Penn State bioengineer Jian Yang is co-principal investigator.
"At present, the prevailing strategy for improving access to medicines for neglected tropical diseases (NTDs) is drug donation programs, which, despite providing some of the highest economic returns of public health programs ... have uncertain sustainability," Francesca Holt of St. John's College at the University of Cambridge and colleagues write in this PLoS Neglected Tropical Diseases opinion piece.
› Verified 6 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
The Indian government plans to set up orphanages in each regional district for female infants in an effort to curb sex-selective abortions, Renuka Chowdhury, minister of women and child development, said, the PTI/Hindustan Times reports.
Aragon Pharmaceuticals today announced the dosing of the first patient in a Phase 1/2 clinical trial of the company's lead compound, ARN-509, in patients with castration-resistant prostate cancer (CRPC).
The study results revealed that patients with a history of heart disease who stopped taking a low-dose daily aspirin had a 60% increased risk of having a heart attack over the three-year follow-up, compared with patients who continued the daily aspirin, says study researcher Luis A. Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research (CEIFE) in Madrid. The study is published in the British Medical Journal.
The National Institutes of Health has awarded grants totaling $3 million for two nanoparticle research projects in which Penn State bioengineer Jian Yang is co-principal investigator.
"At present, the prevailing strategy for improving access to medicines for neglected tropical diseases (NTDs) is drug donation programs, which, despite providing some of the highest economic returns of public health programs ... have uncertain sustainability," Francesca Holt of St. John's College at the University of Cambridge and colleagues write in this PLoS Neglected Tropical Diseases opinion piece.
› Verified 6 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
The Indian government plans to set up orphanages in each regional district for female infants in an effort to curb sex-selective abortions, Renuka Chowdhury, minister of women and child development, said, the PTI/Hindustan Times reports.
Aragon Pharmaceuticals today announced the dosing of the first patient in a Phase 1/2 clinical trial of the company's lead compound, ARN-509, in patients with castration-resistant prostate cancer (CRPC).
The study results revealed that patients with a history of heart disease who stopped taking a low-dose daily aspirin had a 60% increased risk of having a heart attack over the three-year follow-up, compared with patients who continued the daily aspirin, says study researcher Luis A. Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research (CEIFE) in Madrid. The study is published in the British Medical Journal.
The National Institutes of Health has awarded grants totaling $3 million for two nanoparticle research projects in which Penn State bioengineer Jian Yang is co-principal investigator.
"At present, the prevailing strategy for improving access to medicines for neglected tropical diseases (NTDs) is drug donation programs, which, despite providing some of the highest economic returns of public health programs ... have uncertain sustainability," Francesca Holt of St. John's College at the University of Cambridge and colleagues write in this PLoS Neglected Tropical Diseases opinion piece.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Kenneth Mesisca, DO 400 N Pepper Ave, Colton, CA 92324-1801 Ph: (909) 580-6370 | Dr Michael Kenneth Mesisca, DO 400 N Pepper Ave, Colton, CA 92324-1801 Ph: (909) 580-6370 |
News Archive
The Indian government plans to set up orphanages in each regional district for female infants in an effort to curb sex-selective abortions, Renuka Chowdhury, minister of women and child development, said, the PTI/Hindustan Times reports.
Aragon Pharmaceuticals today announced the dosing of the first patient in a Phase 1/2 clinical trial of the company's lead compound, ARN-509, in patients with castration-resistant prostate cancer (CRPC).
The study results revealed that patients with a history of heart disease who stopped taking a low-dose daily aspirin had a 60% increased risk of having a heart attack over the three-year follow-up, compared with patients who continued the daily aspirin, says study researcher Luis A. Garcia Rodriguez, director of the Spanish Center for Pharmacoepidemiologic Research (CEIFE) in Madrid. The study is published in the British Medical Journal.
The National Institutes of Health has awarded grants totaling $3 million for two nanoparticle research projects in which Penn State bioengineer Jian Yang is co-principal investigator.
"At present, the prevailing strategy for improving access to medicines for neglected tropical diseases (NTDs) is drug donation programs, which, despite providing some of the highest economic returns of public health programs ... have uncertain sustainability," Francesca Holt of St. John's College at the University of Cambridge and colleagues write in this PLoS Neglected Tropical Diseases opinion piece.
› Verified 6 days ago
Eugene Lawrence Kwong, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N. Pepper Avenue, Colton, CA 92324 Phone: 909-580-1400 | |
Gregory M. Fenati, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 858-344-7049 | |
Carol Hyeun Lee, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 400 N. Pepper Avenue, Colton, CA 92324 Phone: 909-580-1400 | |
Dr. Vikram Raj, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave Ste 107, Colton, CA 92324 Phone: 909-580-1802 | |
Robert Sexton Kollen, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N. Pepper Avenue, Colton, CA 92324 Phone: 909-580-1400 | |
Leigh Elizabeth Avera, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-1000 | |
Kenneth Paul Takaki, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Pepper Ave, Colton, CA 92324 Phone: 909-580-6370 |